BGMS (Bio Green Med Solution) EBIT: $-3.64 Mil (TTM As of Mar. 2026)

What is Bio Green Med Solution EBIT?

Bio Green Med Solution BGMS -4.49% 47 EBIT is $-3.64 Mil as of Mar. 2026. GuruFocus rates BGMS with a GF Score™ of 47/100 and a GF Value™ of $2.56 (Possible Value Trap). The stock has 3 warning signs investors should review.

Bio Green Med Solution's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-0.25 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.64 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bio Green Med Solution's annualized ROC % for the quarter that ended in Mar. 2026 was -27.77%. Bio Green Med Solution's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -61.44%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Bio Green Med Solution's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -2,031.84%.

Bio Green Med Solution (NAS:BGMS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bio Green Med Solution's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	-0.984 * ( 1 - 0% )	/	( (3.563	+	3.523)	/ 2 )
=	-0.984	/	3.543
=	-27.77 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.185	-	1.117	-	( 3.505	-	max(0, 1.332	-	6.256	+	3.505	))
=	3.563

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	7.564	-	0.702	-	( 3.339	-	max(0, 0.796	-	5.622	+	3.339	))
=	3.523

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Bio Green Med Solution's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2025		Q: Mar. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.984	/	( ( (0.149 + max(1.419, 0))	+	(0.148 + max(1.487, 0)) )	/	2 )
=	-0.984	/	( ( 1.568	+	1.635 )	/	2 )
=	-0.984	/	1.6015
=	-61.44 %

where Working Capital is:

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.257	+	1.384	+	0.11)	-	(1.117	+	0	+	0.215)
=	1.419

	Working Capital		(Q: Mar. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.188	+	0.947	+	0.148)	-	(0.702	+	0	+	0.094)
=	1.487

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bio Green Med Solution's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2026 )
	=	-3.637	/	0.179
	=	-2,031.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Green Med Solution EBIT Related Terms

Bio Green Med Solution EBIT Historical Data

* Premium members only.

The historical data trend for Bio Green Med Solution's EBIT can be seen below:

Bio Green Med Solution EBIT Chart

Bio Green Med Solution Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT

Get a 7-Day Free Trial

-22.39

-27.66

-25.45

-12.00

-8.43

Bio Green Med Solution Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT	Get a 7-Day Free Trial															-4.21	-1.32	-0.99	-1.08	-0.25

BGMS vs FBLG, AIM, APVO: EBIT Comparison

For the Biotechnology subindustry, Bio Green Med Solution's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio Green Med Solution EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio Green Med Solution's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bio Green Med Solution's EV-to-EBIT falls into.

Save Embed

47GF Score

Bio Green Med Solution Inc BGMS

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bio Green Med Solution EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.64 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of $-3.64 Mil mean?

Bio Green Med Solution (BGMS) has a EBIT of $-3.64 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bio Green Med Solution.

Is Bio Green Med Solution's EBIT too high?

Bio Green Med Solution's current EBIT is $-3.64 Mil. Overall, Bio Green Med Solution has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Bio Green Med Solution's EBIT compare to FBLG and AIM?

Bio Green Med Solution's EBIT of $-3.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Biotechnology company?

A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bio Green Med Solution. Bio Green Med Solution's current EBIT is $-3.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bio Green Med Solution stock overvalued right now?

Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.56, compared to a current price of $0.64 — trading 75.1% below its estimated fair value. The current EBIT is $-3.64 Mil. Bio Green Med Solution's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current EBIT is $-3.64 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio Green Med Solution (BGMS) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued. The current stock price of $0.64 is trading 75.1% below its estimated GF Value™ of $2.56. GuruFocus considers Bio Green Med Solution to be Possible Value Trap.

Key valuation signals for BGMS:

EBIT: $-3.64 Mil
GF Value™: $2.56 vs. price of $0.64 (75.1% below fair value)
GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio Green Med Solution Business Description

Industry Healthcare Biotechnology

Comparable Companies FBLG AIM APVO CLGN SPRC CDIO MLEC BCAB RVPH DRMA VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges BGMSP.PFD:USA

Address No. 8 Jalan Kerinchi, Avenue 5, Level 10, Tower 11, Kuala Lumpur, SGR, MYS, 59200

Website https://bgmsglobal.com

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.

47GF Score

Get the complete analysis for BGMS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64

Price

$2.56

GF Value

View BGMS Analysis

See EBIT data for all stocks →